Key Highlights

  • Mobile-health Network Solutions (NASDAQ:MNDR) fell 25.00% pre-market after an unexplained spike, with a Market Value of USD 4 million and an RSI of 73.2, on 1,082,812 shares, on 1,082,812 shares, on 1,082,812 shares, on 1,082,812 shares.
  • DataMeds AI (NASDAQ:MEDS) fell 4.55% pre-market after a share offering, with a market value of USD 10 million and an RSI of 50.7, on 104,924 shares, on 104,924 shares, on 104,924 shares, on 104,924 shares.
  • Picard Medical (NYSEAMERICAN:PMI) fell 6.08% pre-market after a reverse split, with a market value of USD 27 million and an RSI of 76.2, on 667 shares, on 667 shares, on 667 shares, on 667 shares.
  • WISeSat.Space Holdings (NASDAQ:SAIQ) rose 8.36% pre-market after a steep drop, with a market value of USD 62 million and an RSI of 36.3, on 358,544 shares, on 358,544 shares, on 358,544 shares, on 358,544 shares.

Mobile-health Network Solutions (NASDAQ:MNDR): Spike Unwinds Pre-Market

Mobile-health Network Solutions (NASDAQ:MNDR) fell 25.00% pre-market to a listed USD 3.04 on 1,082,812 shares, with a market Capitalization of USD 4 million and an RSI of 73.2 labeled Up, overbought. Mobile-health Network Solutions fell 25.00% pre-market after a roughly 370% spike on October 12, with no catalyst found, on 1.083 million shares. The stock closed near USD 0.85 on October 9 and traded as high as about USD 4 on October 12, so the pre-market price is still far above that close. The company completed a one-for-five reverse split in September 2025, Revenue is about USD 7.3 million to USD 7.6 million, and cash is near USD 1.03 million. The RSI of 73.2 is flagged overbought and the 52-week range runs from USD 0.76 to USD 32.52. A USD 4 million market value and a reverse-split history mean the unwind can be as violent as the spike. By market value it ranks 5 of 5 in this group. What to watch next: regular-session Volume and filings.

DataMeds AI (NASDAQ:MEDS): Reverse Split, Lock-Ups, Offering

DataMeds AI (NASDAQ:MEDS) fell 4.55% pre-market to a listed USD 3.07 on 104,924 shares, with a market capitalization of USD 10 million and an RSI of 50.7 labeled Mixed. DataMeds AI, a Tampa-based health IT company that changed its name from Wellgistics Health in July and moved its ticker from WGRX to MEDS on July 22, uses an AI platform called EinsteinRx and a blockchain contract platform called PharmacyChain. It reported second-quarter 2026 results on August 17, with revenue of USD 1.779 million, up 14% sequentially but down from USD 7.79 million a year earlier, and a loss of USD 7.13 per share on about 2.57 million weighted shares. A 1-for-50 reverse split in May was intended to partially address Nasdaq delisting risk, and the company raised USD 6.5 million in June and restructured USD 14.5 million of Debt toward a preferred Equity swap. Holders of 1,533,930 shares, about 49% of shares outstanding, entered 90-day lock-up agreements, and the board set September 9 for a distribution of Dream Bowl meme coin tokens at 50 per share. Falling revenue, restructured debt, recurring share issuance and a USD 10 million market value make dilution and delisting real risks. By market value it ranks 4 of 5 in this group. What to watch next: offering terms, the lock-up expiry and the Datavault transaction.

Picard Medical (NYSEAMERICAN:PMI): Revenue Up 39%, Reverse Split

Picard Medical (NYSEAMERICAN:PMI) fell 6.08% pre-market to a listed USD 11.34 on 667 shares, with a market capitalization of USD 27 million and an RSI of 76.2 labeled Up, overbought. Picard Medical is the parent of SynCardia Systems, maker of the SynCardia Total Artificial Heart, which is approved by both the FDA and Health Canada and is the only commercially available total artificial heart in the United States and Canada. The company reported second-quarter 2026 results on August 19, with revenue up 39% to about USD 3.0 million on higher US sales of about USD 0.8 million and a net loss that narrowed 16% to about USD 5.7 million. Picard completed a 1-for-50 Reverse Stock Split on July 31, 2026, following stockholder approval, to support compliance with NYSE American standards, and it responded earlier in 2026 to a continued listing notice. In May 2026 it priced a USD 5 million offering of 16,666,667 shares plus warrants exercisable at USD 0.35 before the split, and its September 2025 IPO raised USD 19.6 million at USD 4.00 a share. A USD 27 million market value, negative gross margin, recurring equity raises and a post-split price that can swing on 667 shares make the stock highly volatile. By market value it ranks 3 of 5 in this group. What to watch next: the Emperor heart program, quarterly gross Margin and financing.

WISeSat.Space Holdings (NASDAQ:SAIQ): Bounce After a 17% Drop

WISeSat.Space Holdings (NASDAQ:SAIQ) rose 8.36% pre-market to a listed USD 3.71 on 358,544 shares, with a market capitalization of USD 62 million and an RSI of 36.3 labeled Down. WISeSat.Space rose 8.36% pre-market, tagged as news, after falling 17.31% on October 12, and the specific news item was not located in the filings reviewed. It is a small satellite company with a market value of USD 62 million. Pre-market volume of 358,544 shares is already about a third of the 1.103 million shares traded on October 12. SpaceX's October 8 spectrum deal and the FCC approval of 15,000 mobile satellites put space communications in focus, though any link here is an inference. A bounce after a 17% drop on an unread news tag is not a confirmed reversal. By market value it ranks 2 of 5 in this group. What to watch next: the underlying news item and financing.

Moderna (NASDAQ:MRNA): Valuation Unwind Before ESMO

Moderna (NASDAQ:MRNA) fell 4.30% pre-market to a listed USD 213.74 on 188,532 shares, with a market capitalization of USD 85.33 billion and an RSI of 65.6 labeled Strong up. Moderna fell 4.30% pre-market, with European quotes near EUR 190.49 on October 13 versus EUR 202.00 on October 12, and no new company release was found. The next catalyst is the full intismeran data at ESMO's Presidential Symposium, with an investor event on October 24. Citi downgraded the stock to Sell with a USD 80 target on September 30, and the consensus target is about USD 122.67 with a Hold rating among 23 analysts, far below the USD 213.74 listed price. The stock fell about 7% on October 6, the market value is USD 85.33 billion, and the RSI of 65.6 is labeled Strong up. A price far above analyst targets and a binary data event on October 24 make the stock vulnerable to profit-taking. By market value it ranks 1 of 5 in this group. What to watch next: the October 24 ESMO data and valuation.

Where Things Stand

Monday's movers reversed on Tuesday, which shows how fast momentum names can swing and why chasing them is risky. Mobile-health Network Solutions (NASDAQ:MNDR) fell 25.00%. DataMeds AI (NASDAQ:MEDS) fell 4.55%. Picard Medical (NYSEAMERICAN:PMI) fell 6.08%. WISeSat.Space Holdings (NASDAQ:SAIQ) rose 8.36%. Moderna (NASDAQ:MRNA) fell 4.30%. Pre-market moves on thin volume often reverse, so the balance of evidence favors waiting for the open and for filings. Direction remains unknown, and each name carries its own risks. Verify the latest filings before acting, and treat the figures as a snapshot.